Zhong Ji Longevity Science Group Limited (0767.HK) Stock
Zhong Ji Longevity Science Group Limited operates as an investment holding entity, engaging in a broad spectrum of commercial endeavors. Its operations include providing money lending solutions across Hong Kong and Mainland China.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Peer Comparison
About Zhong Ji Longevity Science Group Limited
Zhong Ji Longevity Science Group Limited operates as an investment holding entity, engaging in a broad spectrum of commercial endeavors. Its operations include providing money lending solutions across Hong Kong and Mainland China. The company's healthcare division delivers diagnostic advisory services, medical examination and testing, and the supply of health-related supplements. Furthermore, Zhong Ji Longevity is involved in holding equity stakes, investing in both short and long-term financial instruments, offering financial and investment advisory, and property acquisition. It also extends health advisory services and deals in medical commodities. Founded in 1994, the company was formerly known as Asia Pacific Silk Road Investment Company Limited before rebranding to its current name in March 2021. Its main office is situated in Causeway Bay, Hong Kong.
Zhong Ji Longevity Science Group Limited is led by CEO Li Yan, employs 43 people, headquartered in Hong Kong, HK, publicly traded since 2005.
over the past 52 weeks the stock has ranged between $0.32 and $0.67, and currently trades 43.3% below its 52-week high.
Official website: www.irasia.com/listco/hk/zhongjilongevity